Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > 5 billion shares traded this morning

<< Previous

Bullboard Posts

Next >>

Comment by toooldtosaveon Dec 21, 2021 2:54pm

122 Views

Post# 34251679

RE:RE:5 billion shares traded this morning

Trades for KALTF so far today
What is this telling us ?

Recent Trades - All 6 today

Time ET	Ex	Price	Change	Volume
11:26:46	Q	0.16062	0.04062	3,000
11:22:03	Q	0.1125	-0.0075	390
11:12:10	Q	0.1927	0.0727	50
11:09:30	Q	0.1125	-0.0075	249
11:09:30	Q	0.114002	-0.005998	249
10:20:46	Q	0.1239	0.0039	302